DR. CHAUDHRY M MUSHTAQ MD NPI 1942281399

NPI Information

  • NPI: 1942281399
  • Provider Name: DR. CHAUDHRY M MUSHTAQ, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 166 STONERIDGE DR
    COLUMBIA, SC
    ZIP 29210
  • Phone: (803) 461-3000

Map and Directions

Get Directions

NPI Details

DR. Chaudhry M Mushtaq, MD is a hematology and oncology internal medicine in Columbia, SC with 41 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Chaudhry M Mushtaq, MD NPI is 1942281399. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

166 STONERIDGE DR
COLUMBIA, SC
ZIP 29210-239
Phone: (803) 461-3000
Fax: (803) 461-4910

The NPI 1942281399 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, granisetron, extended-release, 0.1 mg (HCPCS:J1627)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, gadobutrol, 0.1 ml (HCPCS:A9585)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Liver function blood test panel (HCPCS:80076)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Red blood count, manual test (HCPCS:85044)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Folic acid level, serum (HCPCS:82746)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Magnesium level (HCPCS:83735)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Ct scan of soft tissue of neck with contrast (HCPCS:70491)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • X-ray of chest, 2 views (HCPCS:71046)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Unclassified drugs (HCPCS:J3490)
  • Ct scan of abdomen with contrast (HCPCS:74160)
  • Mri scan of abdomen before and after contrast (HCPCS:74183)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Complete x-ray of body bones (HCPCS:77075)
  • Influenza vaccine split virus, preservative free (HCPCS:90662)
  • Mri scan of brain before and after contrast (HCPCS:70553)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Ct scan of abdomen without contrast (HCPCS:74150)
  • Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
  • Urinalysis using microscope (HCPCS:81015)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • Nuclear medicine study whole body with ct scan (HCPCS:78816)
  • Blood test, clotting time (HCPCS:85610)

The enumeration date for this NPI number is 11/10/2005 and was last updated on 9/17/2007.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology19011SOUTH CAROLINAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1G19220MEDICARE UPIN
2190117MEDICAIDSOUTH CAROLINA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.